Nominee pool grows for stem-cell czar
By San Francisco Chronicle,
San Francisco Chronicle
| 12. 12. 2004
Some of the architects assembling California's $3 billion stem cell project are pushing for a competitive process to select a chairman to lead the experiment, rather than automatically backing the man considered to be the likely candidate for the job.
Robert Klein, the Palo Alto real estate developer, is regarded as the leading contender for the job in part because the peculiar language of the proposition seemed closely tailored to someone with his background. He said last week he would be willing to serve, at least for a while, before he returns to his business ventures.
State officials technically had until today to appoint policy makers to run the California Institute for Regenerative Medicine, which voters created Nov. 2 by passing Proposition 71. As of Friday, only 13 of 29 members had been named to the institute's governing body, known as the Independent Citizens Oversight Committee.
Twenty-seven members will be appointed by various state officials. The last two are supposed to be nominated to the posts of chair and vice chair by four particular state officials -- the governor, lieutenant...
Related Articles
By Carl Zimmer and Marco Hernandez , The New York Times | 07.01.2026
Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team at the University of Minnesota announced that it had taken a major step toward that vision.
Blending together dozens of...
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...
By Ed Pilkington, The Guardian | 06.12.2026
Desperate US parents paying up to $20,000 a session for a procedure scientists say could be bogus
Autistic children as young as 18 months old are being injected with human stem cells derived from umbilical cords in unapproved, unproven and...
By Tobi Thomas, The Guardian | 06.10.2026
The UK’s stem cell transplant system is potentially putting the lives of blood cancer patients at risk as a result of inadequate infrastructure and a lack of long-term planning, a parliamentary report has found.
A hematopoietic stem cell transplant, often...